Provided by Tiger Fintech (Singapore) Pte. Ltd.

NRX Pharmaceuticals Inc.

2.18
-0.0200-0.91%
Post-market: 2.08-0.0999-4.58%19:53 EDT
Volume:139.57K
Turnover:298.37K
Market Cap:36.80M
PE:-1.03
High:2.25
Open:2.21
Low:2.03
Close:2.20
Loading ...

NRx Pharmaceuticals (NASDAQ:NRXP) Announces Publication of Paper Entitled "Quality Assurance of Depression Ratings in Psychiatric Clinical Trials"

PR Newswire
·
25 Nov 2024

NRX Pharmaceuticals Inc (NRXP) Q3 2024 Earnings Call Highlights: Significant Reduction in ...

GuruFocus.com
·
19 Nov 2024

NRx Pharmaceuticals names Michael Abrams as CFO

TIPRANKS
·
19 Nov 2024

NRX Pharmaceuticals Inc - Interim-CFO Richard Narido to Focus on Hope Therapeutics Acquisitions

THOMSON REUTERS
·
19 Nov 2024

NRX Pharmaceuticals (Nasdaq:Nrxp) Appoints Michael Abrams as Chief Financial Officer

THOMSON REUTERS
·
19 Nov 2024

NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Michael Abrams as Chief Financial Officer

PR Newswire
·
19 Nov 2024

NRX Pharmaceuticals Inc reports results for the quarter - Earnings Summary

Reuters
·
15 Nov 2024

Press Release: NRx Pharmaceuticals (NASDAQ:NRXP) Reports Third Quarter and Year to Date 2024 Financial Results and Provides Business Update

Dow Jones
·
15 Nov 2024

NRX Pharmaceuticals Files Registration Statement for Sale of Stock by Shareholders

MT Newswires Live
·
15 Nov 2024

BRIEF-NRx Pharmaceuticals Reschedules Conference Call To Discuss Third Quarter And Year To Date 2024 Financial Results To November 18, 2024

Reuters
·
13 Nov 2024

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024

THOMSON REUTERS
·
13 Nov 2024

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reschedules Conference Call to Discuss Third Quarter and Year to Date 2024 Financial Results to November 18, 2024

PR Newswire
·
13 Nov 2024

NRX Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
13 Nov 2024

NRX Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
09 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 Nov 2024

NRX Pharmaceuticals, Inc. (Nasdaq:Nrxp) to Report Third Quarter and Year to Date 2024 Financial Results on November 14, 2024

THOMSON REUTERS
·
08 Nov 2024